About Dexcom (NASDAQ:DXCM)
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:DXCM
CUSIP25213110
Phone858-200-0200
Debt
Debt-to-Equity Ratio0.78%
Current Ratio5.36%
Quick Ratio5.04%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$718.50 million
Price / Sales9.12
Cash FlowN/A
Price / CashN/A
Book Value$4.83 per share
Price / Book15.41
Profitability
EPS (Most Recent Fiscal Year)($0.58)
Net Income$-50,200,000.00
Net Margins-6.99%
Return on Equity-13.99%
Return on Assets-6.67%
Miscellaneous
Employees2,990
Outstanding Shares88,070,000
Dexcom (NASDAQ:DXCM) Frequently Asked Questions
What is Dexcom's stock symbol?
Dexcom trades on the NASDAQ under the ticker symbol "DXCM."
How were Dexcom's earnings last quarter?
Dexcom (NASDAQ:DXCM) issued its earnings results on Tuesday, February, 27th. The medical device company reported $0.10 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.03 by $0.07. The medical device company earned $221 million during the quarter, compared to analysts' expectations of $217.82 million. Dexcom had a negative net margin of 6.99% and a negative return on equity of 13.99%. View Dexcom's Earnings History.
When is Dexcom's next earnings date?
What price target have analysts set for DXCM?
21 brokers have issued 12-month price targets for Dexcom's stock. Their predictions range from $40.00 to $95.00. On average, they expect Dexcom's share price to reach $67.3824 in the next twelve months. View Analyst Ratings for Dexcom.
Are investors shorting Dexcom?
Dexcom saw a decline in short interest in the month of April. As of April 13th, there was short interest totalling 12,600,819 shares, a decline of 10.9% from the March 30th total of 14,147,733 shares. Based on an average trading volume of 1,326,047 shares, the short-interest ratio is presently 9.5 days. Approximately 14.9% of the company's shares are short sold.
Who are some of Dexcom's key competitors?
Some companies that are related to Dexcom include ResMed (RMD), Abiomed (ABMD), Teleflex (TFX), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Globus Medical (GMED), Cantel Medical (CMD), Penumbra (PEN), Haemonetics (HAE), NuVasive (NUVA), Nevro (NVRO), Merit Medical Systems (MMSI), NovoCure (NVCR) and Irhythm Technologies (IRTC).
Who are Dexcom's key executives?
Dexcom's management team includes the folowing people:
- Mr. Kevin R. Sayer, Chief Exec. Officer, Pres and Director (Age 60)
- Mr. Donald M. Abbey, Exec. VP of Quality & Information Technology (Age 51)
- Mr. Steven R. Pacelli, Exec. VP of Strategy & Corp. Devel. (Age 46)
- Mr. Richard B. Doubleday, Chief Commercial Officer and Exec. VP (Age 55)
- Mr. Terrance H. Gregg, Exec. Chairman (Age 69)
Has Dexcom been receiving favorable news coverage?
News headlines about DXCM stock have trended somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Dexcom earned a media sentiment score of 0.07 on Accern's scale. They also assigned news headlines about the medical device company an impact score of 44.89 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
Who are Dexcom's major shareholders?
Dexcom's stock is owned by a variety of of retail and institutional investors. Top institutional investors include
ARTISAN PARTNERS LIMITED PARTNERSHIP
(2.30%). Company insiders that own Dexcom stock include Andrew K Balo, Barbara Kahn, Jacob Steven Leach, Jay S Skyler, Jeffrey Moy, Jess Roper, John Lister, Jonathan T Md Lord, Jorge A Valdes, Kevin R Sayer, Mark G Foletta, Richard Doubleday, Steven R Altman, Steven Robert Pacelli and Terrance H Gregg. View Institutional Ownership Trends for Dexcom.
How do I buy shares of Dexcom?
Shares of DXCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Dexcom's stock price today?
One share of DXCM stock can currently be purchased for approximately $74.43.
How big of a company is Dexcom?
Dexcom has a market capitalization of $6.46 billion and generates $718.50 million in revenue each year. The medical device company earns $-50,200,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Dexcom employs 2,990 workers across the globe.
How can I contact Dexcom?
Dexcom's mailing address is 6340 SEQUENCE DRIVE, SAN DIEGO CA, 92121. The medical device company can be reached via phone at 858-200-0200 or via email at [email protected]
MarketBeat Community Rating for Dexcom (DXCM)
MarketBeat's community ratings are surveys of what our community members think about Dexcom and other stocks. Vote "Outperform" if you believe DXCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
Dexcom (NASDAQ:DXCM) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
22 Wall Street analysts have issued ratings and price targets for Dexcom in the last 12 months. Their average twelve-month price target is $67.3824, suggesting that the stock has a possible downside of 9.47%. The high price target for DXCM is $95.00 and the low price target for DXCM is $40.00. There are currently 2 sell ratings, 7 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.50 | 2.62 | 2.57 | 2.64 |
| Ratings Breakdown: | 2 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $67.3824 | $67.0294 | $68.50 | $72.1944 |
| Price Target Upside: | 9.47% downside | 0.43% upside | 20.70% upside | 53.02% upside |
Dexcom (NASDAQ:DXCM) Consensus Price Target History
Dexcom (NASDAQ:DXCM) Analyst Ratings History
Show:
(Data available from 4/25/2016 forward)
Dexcom (NASDAQ:DXCM) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Dexcom (NASDAQ DXCM) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.70%
Dexcom (NASDAQ DXCM) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/16/2018 | Terrance H Gregg | Insider | Sell | 10,000 | $73.04 | $730,400.00 | 521,674 |  |
| 3/23/2018 | Richard Doubleday | EVP | Sell | 2,581 | $68.44 | $176,643.64 | 94,429 | |
| 3/15/2018 | Terrance H Gregg | Insider | Sell | 10,000 | $65.51 | $655,100.00 | 521,674 | |
| 2/23/2018 | Richard Doubleday | EVP | Sell | 1,638 | $56.32 | $92,252.16 | 65,049 | |
| 2/15/2018 | Terrance H Gregg | Chairman | Sell | 10,000 | $55.91 | $559,100.00 | 484,559 | |
| 1/23/2018 | Richard Doubleday | EVP | Sell | 1,635 | $54.67 | $89,385.45 | 65,049 | |
| 1/16/2018 | Terrance H Gregg | Insider | Sell | 10,000 | $56.86 | $568,600.00 | 484,559 | |
| 12/26/2017 | Richard Doubleday | EVP | Sell | 1,635 | $56.39 | $92,197.65 | 65,049 | |
| 12/12/2017 | Kevin R. Sayer | CEO | Sell | 6,000 | $58.85 | $353,100.00 | | |
| 12/11/2017 | Andrew K. Balo | EVP | Sell | 3,245 | $61.23 | $198,691.35 | | |
| 11/29/2017 | Andrew K. Balo | EVP | Sell | 6,490 | $60.00 | $389,400.00 | | |
| 11/27/2017 | Mark G Foletta | Director | Sell | 2,500 | $54.95 | $137,375.00 | 4,952 | |
| 11/24/2017 | Richard Doubleday | EVP | Sell | 1,635 | $55.53 | $90,791.55 | 65,049 | |
| 11/20/2017 | Barbara Kahn | Director | Sell | 3,000 | $54.58 | $163,740.00 | 4,353 | |
| 11/20/2017 | Kevin R. Sayer | CEO | Sell | 12,000 | $55.00 | $660,000.00 | | |
| 11/6/2017 | Steven R Altman | Director | Buy | 10,000 | $49.61 | $496,100.00 | 4,353 | |
| 10/23/2017 | Richard Doubleday | EVP | Sell | 1,635 | $44.82 | $73,280.70 | 65,049 | |
| 9/25/2017 | Steven Robert Pacelli | EVP | Sell | 1,450 | $69.81 | $101,224.50 | | |
| 9/20/2017 | Kevin R. Sayer | CEO | Sell | 6,000 | $69.34 | $416,040.00 | | |
| 9/11/2017 | Andrew K. Balo | EVP | Sell | 3,244 | $72.27 | $234,443.88 | | |
| 8/23/2017 | Richard Doubleday | EVP | Sell | 1,635 | $75.26 | $123,050.10 | 72,395 | |
| 8/11/2017 | Kevin R. Sayer | CEO | Sell | 6,000 | $69.77 | $418,620.00 | | |
| 8/10/2017 | Andrew K. Balo | EVP | Sell | 3,244 | $71.18 | $230,907.92 | | |
| 7/24/2017 | Steven Robert Pacelli | EVP | Sell | 1,450 | $69.47 | $100,731.50 | | |
| 7/12/2017 | Kevin R. Sayer | CEO | Sell | 6,000 | $71.86 | $431,160.00 | | |
| 7/10/2017 | Andrew K. Balo | EVP | Sell | 3,200 | $71.55 | $228,960.00 | | |
| 6/23/2017 | Steven Robert Pacelli | EVP | Sell | 1,450 | $78.19 | $113,375.50 | | |
| 6/12/2017 | Andrew K. Balo | EVP | Sell | 3,200 | $69.06 | $220,992.00 | | |
| 6/12/2017 | Kevin R. Sayer | CEO | Sell | 6,000 | $69.07 | $414,420.00 | | |
| 5/23/2017 | Richard Doubleday | EVP | Sell | 3,182 | $68.29 | $217,298.78 | 72,395 | |
| 5/17/2017 | Kevin R Sayer | CEO | Sell | 8,649 | $68.39 | $591,505.11 | 347,329 | |
| 5/10/2017 | Andrew K. Balo | EVP | Sell | 3,200 | $71.93 | $230,176.00 | | |
| 4/24/2017 | Richard Doubleday | EVP | Sell | 3,182 | $75.78 | $241,131.96 | 97,815 | |
| 4/20/2017 | Terrance H Gregg | Insider | Sell | 15,000 | $74.10 | $1,111,500.00 | 454,559 | |
| 4/17/2017 | Kevin R Sayer | CEO | Sell | 10,000 | $75.63 | $756,300.00 | 353,680 | |
| 4/10/2017 | Andrew K. Balo | EVP | Sell | 3,200 | $78.19 | $250,208.00 | | |
| 3/23/2017 | Richard Doubleday | EVP | Sell | 3,182 | $76.38 | $243,041.16 | 97,815 | |
| 3/22/2017 | Jess Roper | CFO | Sell | 2,000 | $75.97 | $151,940.00 | 46,497 | |
| 3/17/2017 | Kevin R Sayer | CEO | Sell | 10,000 | $77.82 | $778,200.00 | 353,680 | |
| 3/14/2017 | Jacob Steven Leach | SVP | Sell | 21,317 | $77.63 | $1,654,838.71 | | |
| 3/13/2017 | Jorge A. Valdes | Insider | Sell | 14,400 | $77.74 | $1,119,456.00 | | |
| 3/9/2017 | John Lister | Insider | Sell | 3,000 | $77.67 | $233,010.00 | | |
| 3/6/2017 | Jay S Skyler | Director | Sell | 31,890 | $78.13 | $2,491,565.70 | 5,011 | |
| 2/23/2017 | Richard Doubleday | EVP | Sell | 3,182 | $78.42 | $249,532.44 | 83,582 | |
| 1/23/2017 | Richard Doubleday | EVP | Sell | 3,182 | $79.50 | $252,969.00 | 83,582 | |
| 1/18/2017 | Jess Roper | CFO | Sell | 3,012 | $85.01 | $256,050.12 | 55,976 | |
| 1/17/2017 | Kevin R Sayer | CEO | Sell | 10,000 | $85.94 | $859,400.00 | 309,391 | |
| 1/13/2017 | John Lister | Insider | Sell | 15,000 | $79.36 | $1,190,400.00 | 85,598 | |
| 1/10/2017 | Andrew K Balo | EVP | Sell | 3,200 | $62.86 | $201,152.00 | 109,545 | |
| 1/9/2017 | Jorge A Valdes | Insider | Sell | 10,900 | $63.02 | $686,918.00 | 79,334 | |
| 12/23/2016 | Richard Doubleday | EVP | Sell | 3,182 | $62.17 | $197,824.94 | 83,582 | |
| 12/9/2016 | Jorge A Valdes | Insider | Sell | 10,000 | $64.81 | $648,100.00 | 74,971 | |
| 10/24/2016 | Jess Roper | CFO | Sell | 2,471 | $80.75 | $199,533.25 | | |
| 10/24/2016 | Steven Robert Pacelli | EVP | Sell | 10,300 | $81.95 | $844,085.00 | | |
| 10/19/2016 | Andrew K. Balo | EVP | Sell | 4,997 | $82.31 | $411,303.07 | | |
| 10/14/2016 | Kevin R. Sayer | CEO | Sell | 7,000 | $81.87 | $573,090.00 | | |
| 10/10/2016 | John Lister | Insider | Sell | 3,560 | $84.41 | $300,499.60 | | |
| 10/5/2016 | Andrew K. Balo | EVP | Sell | 5,000 | $82.55 | $412,750.00 | | |
| 9/23/2016 | Richard Doubleday | EVP | Sell | 3,182 | $93.97 | $299,012.54 | 83,582 | |
| 9/22/2016 | Jess Roper | CFO | Sell | 2,470 | $93.99 | $232,155.30 | | |
| 9/21/2016 | Andrew K. Balo | EVP | Sell | 5,000 | $92.87 | $464,350.00 | | |
| 9/14/2016 | Kevin R. Sayer | CEO | Sell | 7,000 | $91.79 | $642,530.00 | | |
| 9/12/2016 | Jay S Skyler | Director | Sell | 10,000 | $93.00 | $930,000.00 | 5,011 | |
| 9/12/2016 | Jorge A Valdes | Insider | Sell | 19,071 | $93.07 | $1,774,937.97 | 103,667 | |
| 9/9/2016 | Jay S Skyler | Director | Sell | 25,000 | $94.07 | $2,351,750.00 | 5,011 | |
| 9/9/2016 | John Lister | Insider | Sell | 3,560 | $93.65 | $333,394.00 | | |
| 9/8/2016 | Terrance H Gregg | Insider | Sell | 10,740 | $95.29 | $1,023,414.60 | 451,486 | |
| 9/7/2016 | Andrew K Balo | EVP | Sell | 4,999 | $94.45 | $472,155.55 | 135,009 | |
| 9/7/2016 | Mark G. Foletta | Director | Sell | 1,800 | $94.63 | $170,334.00 | | |
| 9/1/2016 | Jonathan T. Md Lord | Director | Sell | 10,000 | $91.50 | $915,000.00 | | |
| 8/30/2016 | Terrance H Gregg | Insider | Sell | 10,000 | $92.14 | $921,400.00 | 451,486 | |
| 8/24/2016 | Andrew K Balo | EVP | Sell | 5,000 | $91.72 | $458,600.00 | 134,979 | |
| 8/24/2016 | Terrance H Gregg | Insider | Sell | 10,000 | $92.72 | $927,200.00 | 451,486 | |
| 8/23/2016 | Steven Robert Pacelli | EVP | Sell | 10,300 | $90.74 | $934,622.00 | | |
| 8/23/2016 | Terrance H Gregg | Chairman | Sell | 10,000 | $91.11 | $911,100.00 | 451,486 | |
| 8/22/2016 | Terrance H Gregg | Chairman | Sell | 10,000 | $90.51 | $905,100.00 | 451,486 | |
| 8/19/2016 | Jay S Skyler | Director | Sell | 25,000 | $90.77 | $2,269,250.00 | 5,011 | |
| 8/19/2016 | Terrance H Gregg | Insider | Sell | 40,000 | $90.70 | $3,628,000.00 | 451,486 | |
| 8/15/2016 | Kevin R. Sayer | CEO | Sell | 7,000 | $90.78 | $635,460.00 | | |
| 8/15/2016 | Terrance H Gregg | Chairman | Sell | 14,942 | $91.01 | $1,359,871.42 | 451,486 | |
| 8/12/2016 | Jonathan T. Md Lord | Director | Sell | 10,000 | $90.64 | $906,400.00 | | |
| 8/11/2016 | Terrance H Gregg | Insider | Sell | 10,900 | $91.03 | $992,227.00 | 451,486 | |
| 8/10/2016 | Andrew K Balo | EVP | Sell | 5,000 | $90.26 | $451,300.00 | 134,979 | |
| 8/9/2016 | Jorge A Valdes | Insider | Sell | 32,000 | $91.06 | $2,913,920.00 | 123,667 | |
| 8/9/2016 | Kevin R Sayer | CEO | Sell | 20,000 | $90.98 | $1,819,600.00 | 362,227 | |
| 8/8/2016 | Barbara Kahn | Director | Sell | 6,000 | $90.52 | $543,120.00 | 12,291 | |
| 8/5/2016 | Terrance H. Gregg | Insider | Sell | 35,000 | $79.81 | $2,793,350.00 | | |
| 8/1/2016 | Jeffrey Moy | SVP | Sell | 15,000 | $92.33 | $1,384,950.00 | 107,582 | |
| 7/27/2016 | Andrew K Balo | EVP | Sell | 5,000 | $88.14 | $440,700.00 | 134,979 | |
| 7/25/2016 | Richard Doubleday | EVP | Sell | 3,182 | $87.31 | $277,820.42 | 92,250 | |
| 7/22/2016 | Jeffrey Moy | SVP | Sell | 10,000 | $88.48 | $884,800.00 | 76,333 | |
| 7/19/2016 | Jeffrey Moy | SVP | Sell | 12,843 | $83.78 | $1,075,986.54 | | |
| 7/13/2016 | Andrew K Balo | EVP | Sell | 5,000 | $80.12 | $400,600.00 | 134,979 | |
| 7/13/2016 | Kevin R. Sayer | CEO | Sell | 7,000 | $79.92 | $559,440.00 | | |
| 7/11/2016 | Jorge A Valdes | Insider | Sell | 32,000 | $79.36 | $2,539,520.00 | 123,667 | |
| 6/29/2016 | Andrew K Balo | EVP | Sell | 5,000 | $78.10 | $390,500.00 | 134,979 | |
| 6/29/2016 | Jeffrey Moy | SVP | Sell | 4,557 | $80.00 | $364,560.00 | 76,333 | |
| 6/23/2016 | Steven Robert Pacelli | EVP | Sell | 10,300 | $77.40 | $797,220.00 | | |
| 6/20/2016 | Andrew K Balo | EVP | Sell | 55,000 | $75.00 | $4,125,000.00 | 184,979 | |
| 6/20/2016 | Jeffrey Moy | SVP | Sell | 7,209 | $77.00 | $555,093.00 | 76,333 | |
| 6/20/2016 | Kevin R. Sayer | CEO | Sell | 35,000 | $75.00 | $2,625,000.00 | | |
| 6/9/2016 | Jeffrey Moy | SVP | Sell | 6,910 | $74.00 | $511,340.00 | 76,333 | |
| 6/9/2016 | John Lister | Insider | Sell | 3,560 | $73.27 | $260,841.20 | 65,894 | |
| 6/8/2016 | Jeffrey Moy | SVP | Sell | 6,866 | $71.00 | $487,486.00 | 76,333 | |
| 6/8/2016 | Jorge A Valdes | Insider | Sell | 18,038 | $72.06 | $1,299,818.28 | 101,667 | |
| 6/8/2016 | Steven Robert Pacelli | EVP | Sell | 18,239 | $70.88 | $1,292,780.32 | 182,518 | |
| 6/7/2016 | Jess Roper | CFO | Sell | 3,471 | $69.00 | $239,499.00 | 85,248 | |
| 5/23/2016 | Richard Doubleday | EVP | Sell | 1,674 | $63.59 | $106,449.66 | 94,900 | |
| 5/18/2016 | Jorge A Valdes | Insider | Sell | 20,000 | $61.75 | $1,235,000.00 | 111,667 | |
| 5/16/2016 | Terrance H Gregg | Chairman | Sell | 20,000 | $62.72 | $1,254,400.00 | 472,991 | |
| 5/12/2016 | Barbara Kahn | Director | Sell | 3,000 | $60.72 | $182,160.00 | 42,804 | |
| 5/11/2016 | Terrance H Gregg | Chairman | Sell | 8,600 | $64.32 | $553,152.00 | 472,991 | |
| 5/9/2016 | John Lister | Insider | Sell | 3,560 | $62.50 | $222,500.00 | 69,454 | |
| 5/9/2016 | Terrance H Gregg | Chairman | Sell | 12,168 | $62.42 | $759,526.56 | 472,991 | |
| 4/27/2016 | Jorge A Valdes | Insider | Sell | 10,000 | $70.00 | $700,000.00 | 91,667 | |
| 4/27/2016 | Steven Robert Pacelli | EVP | Sell | 2,361 | $70.39 | $166,190.79 | 201,757 | |
| 4/25/2016 | Jess Roper | CFO | Sell | 3,471 | $69.00 | $239,499.00 | 88,719 | |
| 4/25/2016 | Richard Doubleday | EVP | Sell | 1,666 | $69.15 | $115,203.90 | 94,900 | |
| 4/12/2016 | John Lister | Insider | Sell | 3,704 | $65.78 | $243,649.12 | 73,014 | |
| 4/11/2016 | Terrance H Gregg | Chairman | Sell | 2,169 | $68.00 | $147,492.00 | 475,159 | |
| 4/4/2016 | Jorge A Valdes | Insider | Sell | 20,000 | $70.08 | $1,401,600.00 | 111,667 | |
| 4/4/2016 | Steven Robert Pacelli | EVP | Sell | 20,600 | $70.62 | $1,454,772.00 | 204,118 | |
| 3/31/2016 | Jess Roper | CFO | Sell | 3,470 | $69.00 | $239,430.00 | 92,190 | |
| 3/23/2016 | Richard Doubleday | EVP | Sell | 1,666 | $61.76 | $102,892.16 | 123,022 | |
| 3/22/2016 | Terrance H Gregg | Chairman | Sell | 25,000 | $59.51 | $1,487,750.00 | 477,328 | |
| 3/14/2016 | John Lister | Insider | Sell | 3,560 | $63.75 | $226,950.00 | 80,278 | |
| 3/7/2016 | Barbara Kahn | Director | Sell | 5,000 | $67.04 | $335,200.00 | 45,804 | |
| 2/23/2016 | Richard Doubleday | EVP | Sell | 1,666 | $64.36 | $107,223.76 | 100,483 | |
| 2/18/2016 | John Lister | VP | Sell | 3,560 | $62.50 | $222,500.00 | | |
| 1/25/2016 | Steven Robert Pacelli | EVP | Sell | 10,300 | $73.24 | $754,372.00 | 205,914 | |
| 1/22/2016 | Jess Roper | CFO | Sell | 3,518 | $72.97 | $256,708.46 | 75,989 | |
| 1/20/2016 | Kevin R Sayer | CEO | Sell | 7,000 | $75.00 | $525,000.00 | 336,402 | |
| 1/12/2016 | Jorge A Valdes | Insider | Sell | 5,610 | $80.16 | $449,697.60 | 92,437 | |
| 1/11/2016 | Jorge A Valdes | Insider | Sell | 1,641 | $78.43 | $128,703.63 | 92,437 | |
| 1/8/2016 | John Lister | VP | Sell | 3,560 | $82.57 | $293,949.20 | 97,710 | |
| 12/23/2015 | Richard Doubleday | EVP | Sell | 1,666 | $82.22 | $136,978.52 | 100,483 | |
| 12/22/2015 | Jess Roper | CFO | Sell | 3,417 | $81.19 | $277,426.23 | 79,507 | |
| 12/17/2015 | Andrew K. Balo | EVP | Sell | 7,500 | $82.52 | $618,900.00 | 107,680 | |
| 12/14/2015 | John Lister | VP | Sell | 3,560 | $82.50 | $293,700.00 | 101,270 | |
| 12/9/2015 | Jorge A. Valdes | insider | Sell | 10,000 | $85.74 | $857,400.00 | 92,437 | |
| 12/8/2015 | John Lister | VP | Sell | 2,476 | $87.16 | $215,808.16 | 104,830 | |
| 12/4/2015 | Terrance H. Gregg | Chairman | Sell | 10,000 | $86.79 | $867,900.00 | 459,018 | |
| 12/3/2015 | Andrew K. Balo | EVP | Sell | 7,500 | $86.37 | $647,775.00 | 107,680 | |
| 12/2/2015 | Terrance H. Gregg | Chairman | Sell | 10,000 | $87.05 | $870,500.00 | 459,018 | |
| 11/30/2015 | Terrance H. Gregg | Chairman | Sell | 5,000 | $86.50 | $432,500.00 | 459,018 | |
| 11/25/2015 | Andrew K. Balo | EVP | Sell | 7,500 | $87.49 | $656,175.00 | 107,680 | |
| 11/25/2015 | Terrance H. Gregg | Chairman | Sell | 15,000 | $87.53 | $1,312,950.00 | 459,018 | |
| 11/24/2015 | Andrew K. Balo | EVP | Sell | 10,000 | $86.43 | $864,300.00 | 107,680 | |
| 11/24/2015 | Terrance H. Gregg | Chairman | Sell | 15,497 | $86.54 | $1,341,110.38 | 459,018 | |
| 11/23/2015 | Richard Doubleday | EVP | Sell | 1,666 | $85.85 | $143,026.10 | 100,483 | |
| 11/20/2015 | Terrance H. Gregg | Chairman | Sell | 22,003 | $86.48 | $1,902,819.44 | 459,018 | |
| 11/18/2015 | Jess Roper | CFO | Sell | 7,000 | $84.15 | $589,050.00 | 82,924 | |
| 11/16/2015 | Terrance H. Gregg | Chairman | Sell | 20,000 | $83.89 | $1,677,800.00 | 459,018 | |
| 11/12/2015 | Jess Roper | CFO | Sell | 20,000 | $84.07 | $1,681,400.00 | 83,924 | |
| 11/11/2015 | Andrew K. Balo | EVP | Sell | 7,500 | $84.50 | $633,750.00 | 113,157 | |
| 10/23/2015 | Richard Doubleday | EVP | Sell | 1,666 | $79.27 | $132,063.82 | 100,483 | |
| 10/20/2015 | Andrew K Balo | EVP | Sell | 4,538 | $81.46 | $369,665.48 | 113,157 | |
| 10/19/2015 | Jess Roper | CFO | Sell | 7,000 | $83.37 | $583,590.00 | 98,424 | |
| 10/15/2015 | Terrance H Gregg | Chairman | Sell | 15,000 | $77.92 | $1,168,800.00 | 459,018 | |
| 10/6/2015 | Andrew K Balo | EVP | Sell | 8,216 | $82.29 | $676,094.64 | 117,695 | |
| 9/23/2015 | Steven Robert Pacelli | EVP | Sell | 14,000 | $98.08 | $1,373,120.00 | 216,214 | |
| 9/21/2015 | Andrew K Balo | EVP | Sell | 7,859 | $100.72 | $791,558.48 | 125,911 | |
| 9/18/2015 | Jess Roper | CFO | Sell | 7,000 | $101.22 | $708,540.00 | 99,424 | |
| 9/15/2015 | Terrance H. Gregg | Chairman | Sell | 29,999 | $96.22 | $2,886,503.78 | 459,018 | |
| 9/11/2015 | Terrance H. Gregg | Chairman | Sell | 47,500 | $96.50 | $4,583,750.00 | 459,018 | |
| 9/10/2015 | Terrance H. Gregg | Chairman | Sell | 62,501 | $95.91 | $5,994,470.91 | 459,018 | |
| 9/9/2015 | Jonathan T Md Lord | Director | Sell | 10,000 | $90.96 | $909,600.00 | 131,582 | |
| 9/8/2015 | Andrew K Balo | EVP | Sell | 7,500 | $89.53 | $671,475.00 | 142,590 | |
| 9/8/2015 | John Lister | VP | Sell | 2,642 | $89.36 | $236,089.12 | 121,347 | |
| 9/8/2015 | Terrance H. Gregg | Chairman | Sell | 25,000 | $90.85 | $2,271,250.00 | 459,018 | |
| 9/1/2015 | Jeffrey Moy | SVP | Sell | 8,881 | $90.61 | $804,707.41 | 90,000 | |
| 9/1/2015 | Jorge A. Valdes | insider | Sell | 20,000 | $91.22 | $1,824,400.00 | 116,207 | |
| 8/28/2015 | Steven Robert Pacelli | EVP | Sell | 19,854 | $94.67 | $1,879,578.18 | 228,792 | |
| 8/24/2015 | Steven Robert Pacelli | EVP | Sell | 14,000 | $84.18 | $1,178,520.00 | 248,646 | |
| 8/20/2015 | Andrew K Balo | EVP | Sell | 7,500 | $92.47 | $693,525.00 | 150,090 | |
| 8/18/2015 | Steven R Altman | Director | Sell | 5,000 | $96.69 | $483,450.00 | | |
| 8/17/2015 | Jay S Skyler | Director | Sell | 20,000 | $96.65 | $1,933,000.00 | | |
| 8/17/2015 | Terrance H Gregg | Chairman | Sell | 15,000 | $96.71 | $1,450,650.00 | | |
| 8/14/2015 | Kevin R Sayer | CEO | Sell | 35,000 | $97.41 | $3,409,350.00 | | |
| 7/23/2015 | Richard Doubleday | EVP | Sell | 9,641 | $85.37 | $823,052.17 | | |
| 7/22/2015 | Andrew K Balo | EVP | Sell | 10,214 | $84.78 | $865,942.92 | | |
| 7/21/2015 | Jeffrey Moy | SVP | Sell | 3,786 | $83.48 | $316,055.28 | | |
| 7/20/2015 | Jess Roper | CFO | Sell | 7,000 | $83.74 | $586,180.00 | | |
| 7/17/2015 | Terrance H Gregg | Chairman | Sell | 50,750 | $83.07 | $4,215,802.50 | | |
| 7/15/2015 | Jay S Skyler | Director | Sell | 20,000 | $81.69 | $1,633,800.00 | | |
| 7/8/2015 | Andrew K Balo | EVP | Sell | 4,494 | $80.22 | $360,508.68 | | |
| 7/8/2015 | John Lister | VP | Sell | 1,776 | $79.94 | $141,973.44 | | |
| 7/8/2015 | Jorge A Valdes | Insider | Sell | 50,000 | $79.83 | $3,991,500.00 | | |
| 7/7/2015 | Jeffrey Moy | SVP | Sell | 5,000 | $79.32 | $396,600.00 | | |
| 6/23/2015 | Jeffrey Moy | SVP | Sell | 5,154 | $77.54 | $399,641.16 | | |
| 6/23/2015 | Steven Robert Pacelli | EVP | Sell | 14,000 | $77.53 | $1,085,420.00 | | |
| 6/18/2015 | Jess Roper | CFO | Sell | 7,000 | $77.10 | $539,700.00 | | |
| 6/15/2015 | Jay S Skyler | Director | Sell | 20,000 | $70.67 | $1,413,400.00 | | |
| 6/15/2015 | Terrance H Gregg | Chairman | Sell | 15,000 | $70.94 | $1,064,100.00 | | |
| 6/12/2015 | Terrance H. Gregg | Chairman | Sell | 25,000 | $72.30 | $1,807,500.00 | 459,018 | |
| 6/11/2015 | Jeffrey Moy | SVP | Sell | 9,869 | $73.00 | $720,437.00 | | |
| 6/9/2015 | Andrew K Balo | EVP | Sell | 7,500 | $70.62 | $529,650.00 | | |
| 6/9/2015 | Jeffrey Moy | SVP | Sell | 5,000 | $70.63 | $353,150.00 | | |
| 6/9/2015 | Jorge A Valdes | Insider | Sell | 19,680 | $71.32 | $1,403,577.60 | | |
| 6/8/2015 | John Lister | VP | Sell | 1,776 | $72.03 | $127,925.28 | | |
| 6/8/2015 | Jorge A Valdes | Insider | Sell | 8,243 | $72.07 | $594,073.01 | | |
| 6/3/2015 | Terrance H Gregg | Chairman | Sell | 40,000 | $72.77 | $2,910,800.00 | | |
| 6/2/2015 | Terrance H Gregg | Chairman | Sell | 5,000 | $73.12 | $365,600.00 | | |
| 6/1/2015 | Terrance H Gregg | Chairman | Sell | 10,000 | $72.75 | $727,500.00 | | |
| 5/27/2015 | Jeffrey Moy | SVP | Sell | 21,791 | $69.60 | $1,516,653.60 | | |
| 5/27/2015 | Richard Doubleday | EVP | Sell | 3,258 | $70.73 | $230,438.34 | | |
| 5/18/2015 | Andrew K Balo | EVP | Sell | 7,500 | $68.46 | $513,450.00 | | |
| 5/18/2015 | Jeffrey Moy | SVP | Sell | 15,586 | $69.20 | $1,078,551.20 | | |
| 5/18/2015 | Jess Roper | CFO | Sell | 7,000 | $69.27 | $484,890.00 | | |
| 5/15/2015 | Terrance H Gregg | Chairman | Sell | 82,500 | $69.24 | $5,712,300.00 | | |
| 5/12/2015 | Jeffrey Moy | SVP | Sell | 20,303 | $67.84 | $1,377,355.52 | | |
| 5/12/2015 | Jorge A Valdes | Insider | Sell | 30,878 | $68.27 | $2,108,041.06 | | |
| 5/11/2015 | Jeffrey Moy | SVP | Sell | 15,303 | $68.25 | $1,044,429.75 | | |
| 5/11/2015 | Terrance H Gregg | Chairman | Sell | 3,517 | $68.65 | $241,442.05 | | |
| 5/8/2015 | Terrance H Gregg | Chairman | Sell | 91,483 | $67.85 | $6,207,121.55 | | |
| 5/4/2015 | Kevin R Sayer | CEO | Sell | 25,000 | $68.01 | $1,700,250.00 | | |
| 4/28/2015 | Jeffrey Moy | SVP | Sell | 10,000 | $68.41 | $684,100.00 | | |
| 4/27/2015 | Jeffrey Moy | SVP | Sell | 5,000 | $69.27 | $346,350.00 | | |
| 4/23/2015 | Steven Robert Pacelli | EVP | Sell | 39,709 | $69.63 | $2,764,937.67 | | |
| 4/20/2015 | Jess Roper | CFO | Sell | 7,000 | $68.05 | $476,350.00 | | |
| 4/15/2015 | Terrance H Gregg | Chairman | Sell | 15,000 | $67.56 | $1,013,400.00 | | |
| 4/14/2015 | Jeffrey Moy | SVP | Sell | 20,766 | $66.63 | $1,383,638.58 | | |
| 4/9/2015 | Andrew K Balo | EVP | Sell | 7,500 | $64.55 | $484,125.00 | | |
| 4/9/2015 | Jorge A Valdes | Insider | Sell | 19,684 | $64.38 | $1,267,255.92 | | |
| 4/8/2015 | John Lister | VP | Sell | 5,039 | $63.84 | $321,689.76 | | |
| 3/25/2015 | Andrew K Balo | EVP | Sell | 7,500 | $61.05 | $457,875.00 | | |
| 3/23/2015 | Steven Robert Pacelli | EVP | Sell | 14,000 | $61.33 | $858,620.00 | | |
| 3/18/2015 | Jess Roper | CFO | Sell | 7,000 | $62.43 | $437,010.00 | | |
| 3/17/2015 | Terrance H Gregg | Chairman | Sell | 15,000 | $62.82 | $942,300.00 | | |
| 3/13/2015 | Jay S Skyler | Director | Sell | 45,000 | $60.01 | $2,700,450.00 | | |
| 3/12/2015 | Jorge A Valdes | Insider | Sell | 11,138 | $59.78 | $665,829.64 | | |
| 3/12/2015 | Richard Doubleday | EVP | Sell | 20,000 | $59.23 | $1,184,600.00 | | |
| 3/9/2015 | John Lister | VP | Sell | 5,039 | $58.77 | $296,142.03 | | |
| 3/9/2015 | Jorge A Valdes | Insider | Sell | 8,244 | $58.77 | $484,499.88 | | |
| 2/23/2015 | Richard Doubleday | EVP | Sell | 4,000 | $63.58 | $254,320.00 | | |
| 2/9/2015 | John Lister | VP | Sell | 5,039 | $61.66 | $310,704.74 | | |
| 2/9/2015 | Jorge A Valdes | Insider | Sell | 8,244 | $61.67 | $508,407.48 | | |
| 2/2/2015 | Jeffrey Moy | SVP | Sell | 5,000 | $60.69 | $303,450.00 | | |
| 1/26/2015 | Steven Robert Pacelli | EVP | Sell | 24,532 | $59.67 | $1,463,824.44 | | |
| 1/23/2015 | Richard Doubleday | EVP | Sell | 4,000 | $58.22 | $232,880.00 | | |
| 1/20/2015 | Jeffrey Moy | SVP | Sell | 5,000 | $57.58 | $287,900.00 | | |
| 1/20/2015 | Jess Roper | CFO | Sell | 7,000 | $57.34 | $401,380.00 | | |
| 1/15/2015 | Terrance H Gregg | Chairman | Sell | 15,000 | $57.84 | $867,600.00 | | |
| 1/13/2015 | Steven Robert Pacelli | EVP | Sell | 9,468 | $62.22 | $589,098.96 | | |
| 1/12/2015 | Steven Robert Pacelli | EVP | Sell | 20,000 | $59.18 | $1,183,600.00 | | |
| 1/9/2015 | Jorge A Valdes | Insider | Sell | 9,170 | $57.55 | $527,733.50 | | |
| 1/8/2015 | John Lister | VP | Sell | 5,039 | $57.42 | $289,339.38 | | |
| 1/5/2015 | Jeffrey Moy | SVP | Sell | 5,000 | $55.27 | $276,350.00 | | |
| 12/26/2014 | Andrew K Balo | SVP | Sell | 10,000 | $55.27 | $552,700.00 | | |
| 12/23/2014 | Richard Doubleday | VP | Sell | 4,000 | $54.69 | $218,760.00 | | |
| 12/23/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $54.62 | $764,680.00 | | |
| 12/18/2014 | Jess Roper | CFO | Sell | 12,000 | $56.43 | $677,160.00 | | |
| 12/15/2014 | Terrance H Gregg | CEO | Sell | 35,000 | $53.23 | $1,863,050.00 | | |
| 12/8/2014 | Jorge A Valdes | Insider | Sell | 16,000 | $56.03 | $896,480.00 | | |
| 12/3/2014 | Eric Topol | Director | Sell | 20,000 | $55.00 | $1,100,000.00 | | |
| 11/28/2014 | Terrance H Gregg | CEO | Sell | 59,990 | $51.51 | $3,090,084.90 | | |
| 11/25/2014 | Andrew K Balo | SVP | Sell | 10,000 | $51.11 | $511,100.00 | | |
| 11/25/2014 | Terrance H Gregg | CEO | Sell | 55,010 | $51.04 | $2,807,710.40 | | |
| 11/24/2014 | Richard Doubleday | VP | Sell | 4,000 | $50.36 | $201,440.00 | | |
| 11/24/2014 | Terrance H Gregg | CEO | Sell | 35,000 | $51.06 | $1,787,100.00 | | |
| 11/21/2014 | Terrance H Gregg | CEO | Sell | 10,000 | $50.50 | $505,000.00 | | |
| 11/19/2014 | Terrance H Gregg | CEO | Sell | 10,000 | $51.00 | $510,000.00 | | |
| 11/17/2014 | Terrance H Gregg | CEO | Sell | 45,000 | $52.52 | $2,363,400.00 | | |
| 11/12/2014 | Terrance H Gregg | CEO | Sell | 80,000 | $53.36 | $4,268,800.00 | | |
| 11/10/2014 | Jorge A Valdes | Insider | Sell | 16,000 | $51.23 | $819,680.00 | | |
| 10/27/2014 | Andrew K Balo | SVP | Sell | 10,000 | $42.98 | $429,800.00 | | |
| 10/23/2014 | Richard Doubleday | VP | Sell | 4,000 | $43.58 | $174,320.00 | | |
| 10/23/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $43.60 | $610,400.00 | | |
| 10/13/2014 | Andrew K Balo | SVP | Sell | 10,000 | $40.42 | $404,200.00 | | |
| 10/13/2014 | John Lister | VP | Sell | 3,400 | $40.41 | $137,394.00 | | |
| 10/8/2014 | Jorge A Valdes | Insider | Sell | 16,000 | $40.29 | $644,640.00 | | |
| 9/25/2014 | Andrew K Balo | SVP | Sell | 10,000 | $40.71 | $407,100.00 | | |
| 9/23/2014 | Richard Doubleday | VP | Sell | 4,000 | $40.32 | $161,280.00 | | |
| 9/23/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $40.32 | $564,480.00 | | |
| 9/18/2014 | Jess Roper | CFO | Sell | 8,000 | $41.91 | $335,280.00 | | |
| 9/15/2014 | Terrance H Gregg | CEO | Sell | 35,000 | $41.14 | $1,439,900.00 | | |
| 9/12/2014 | John Lister | VP | Sell | 3,518 | $43.70 | $153,736.60 | | |
| 9/11/2014 | Andrew K Balo | SVP | Sell | 10,000 | $42.97 | $429,700.00 | | |
| 9/8/2014 | Jorge A Valdes | Insider | Sell | 16,000 | $42.98 | $687,680.00 | | |
| 8/28/2014 | Barbara Kahn | Director | Sell | 4,000 | $44.52 | $178,080.00 | | |
| 8/26/2014 | Jeffrey Moy | SVP | Sell | 16,663 | $45.30 | $754,833.90 | | |
| 8/26/2014 | Jonathan T Md Lord | Director | Sell | 20,000 | $45.56 | $911,200.00 | | |
| 8/26/2014 | Steven Robert Pacelli | EVP | Sell | 30,000 | $44.56 | $1,336,800.00 | | |
| 8/26/2014 | Terrance H Gregg | CEO | Sell | 5,000 | $46.05 | $230,250.00 | | |
| 8/25/2014 | Andrew K Balo | SVP | Sell | 10,000 | $44.12 | $441,200.00 | | |
| 8/25/2014 | Richard Doubleday | VP | Sell | 4,000 | $44.35 | $177,400.00 | | |
| 8/25/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $44.24 | $619,360.00 | | |
| 8/22/2014 | Andrew K Balo | SVP | Sell | 20,000 | $44.24 | $884,800.00 | | |
| 8/22/2014 | Terrance H Gregg | CEO | Sell | 13,607 | $44.46 | $604,967.22 | | |
| 8/21/2014 | Barbara Kahn | Director | Sell | 2,200 | $43.42 | $95,524.00 | | |
| 8/21/2014 | Jorge A Valdes | Insider | Sell | 10,671 | $43.58 | $465,042.18 | | |
| 8/21/2014 | Terrance H Gregg | CEO | Sell | 23,893 | $44.36 | $1,059,893.48 | | |
| 8/19/2014 | Richard Doubleday | VP | Sell | 20,000 | $45.01 | $900,200.00 | | |
| 8/19/2014 | Terrance H Gregg | CEO | Sell | 75,000 | $45.08 | $3,381,000.00 | | |
| 8/18/2014 | Terrance H Gregg | CEO | Sell | 65,000 | $44.16 | $2,870,400.00 | | |
| 8/14/2014 | Terrance H Gregg | CEO | Sell | 25,000 | $44.24 | $1,106,000.00 | | |
| 8/13/2014 | Terrance H Gregg | CEO | Sell | 56,107 | $43.57 | $2,444,581.99 | | |
| 8/11/2014 | Andrew K Balo | SVP | Sell | 10,000 | $44.24 | $442,400.00 | | |
| 8/11/2014 | Kevin R Sayer | COO | Sell | 20,000 | $43.82 | $876,400.00 | | |
| 8/8/2014 | Jorge A Valdes | Insider | Sell | 16,000 | $43.56 | $696,960.00 | | |
| 7/25/2014 | Andrew K Balo | SVP | Sell | 10,000 | $38.19 | $381,900.00 | | |
| 7/23/2014 | Richard Doubleday | VP | Sell | 4,000 | $38.16 | $152,640.00 | | |
| 7/23/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $38.28 | $535,920.00 | | |
| 7/18/2014 | Jess Roper | CFO | Sell | 8,000 | $36.01 | $288,080.00 | | |
| 7/15/2014 | Terrance H Gregg | CEO | Sell | 35,000 | $36.66 | $1,283,100.00 | | |
| 7/14/2014 | John Lister | VP | Sell | 3,500 | $36.59 | $128,065.00 | | |
| 7/11/2014 | Andrew K Balo | SVP | Sell | 10,000 | $35.93 | $359,300.00 | | |
| 7/8/2014 | Jorge A Valdes | Insider | Sell | 16,000 | $36.66 | $586,560.00 | | |
| 7/2/2014 | Jay S Skyler | Director | Sell | 30,000 | $40.05 | $1,201,500.00 | | |
| 6/25/2014 | Andrew K Balo | SVP | Sell | 10,000 | $40.60 | $406,000.00 | | |
| 6/23/2014 | Richard Doubleday | VP | Sell | 4,000 | $40.98 | $163,920.00 | | |
| 6/23/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $41.02 | $574,280.00 | | |
| 6/20/2014 | Jay S Skyler | Director | Sell | 60,000 | $40.00 | $2,400,000.00 | | |
| 6/18/2014 | Jess Roper | CFO | Sell | 8,000 | $39.17 | $313,360.00 | | |
| 6/16/2014 | Terrance H Gregg | CEO | Sell | 35,000 | $37.23 | $1,303,050.00 | | |
| 6/12/2014 | John Lister | VP | Sell | 3,500 | $36.13 | $126,455.00 | | |
| 6/11/2014 | Andrew K Balo | SVP | Sell | 10,000 | $36.63 | $366,300.00 | | |
| 6/9/2014 | Jorge A Valdes | Insider | Sell | 16,000 | $36.68 | $586,880.00 | | |
| 6/5/2014 | Richard Doubleday | VP | Sell | 4,000 | $35.59 | $142,360.00 | | |
| 5/27/2014 | Andrew K Balo | SVP | Sell | 10,000 | $33.86 | $338,600.00 | | |
| 5/19/2014 | Jess Roper | CFO | Sell | 8,000 | $32.20 | $257,600.00 | 87,786 | |
| 5/8/2014 | Jorge Valdes | Insider | Sell | 16,000 | $29.83 | $477,280.00 | 217,487 | |
| 4/25/2014 | Andrew Balo | SVP | Sell | 10,000 | $34.35 | $343,500.00 | 159,099 | |
| 4/23/2014 | Richard Doubleday | VP | Sell | 4,000 | $35.92 | $143,680.00 | 147,523 | |
| 4/23/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $35.90 | $502,600.00 | 241,399 | |
| 4/21/2014 | Jess Roper | CFO | Sell | 8,000 | $36.18 | $289,440.00 | 87,786 | |
| 4/15/2014 | Terrance Gregg | CEO | Sell | 35,000 | $34.09 | $1,193,150.00 | 395,626 | |
| 4/14/2014 | John Lister | VP | Sell | 2,884 | $35.86 | $103,420.24 | 119,408 | |
| 4/11/2014 | Andrew Balo | SVP | Sell | 10,000 | $35.36 | $353,600.00 | 159,099 | |
| 4/8/2014 | Jorge Valdes | Insider | Sell | 16,000 | $35.99 | $575,840.00 | 217,487 | |
| 3/26/2014 | Jay Skyler | Director | Sell | 30,000 | $43.05 | $1,291,500.00 | | |
| 3/25/2014 | Andrew Balo | SVP | Sell | 10,000 | $43.00 | $430,000.00 | 159,099 | |
| 3/24/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $42.92 | $600,880.00 | 241,399 | |
| 3/18/2014 | Jess Roper | CFO | Sell | 8,000 | $46.00 | $368,000.00 | 87,786 | |
| 3/17/2014 | Terrance Gregg | CEO | Sell | 45,000 | $45.25 | $2,036,250.00 | 395,626 | |
| 3/12/2014 | Terrance Gregg | CEO | Sell | 30,000 | $45.50 | $1,365,000.00 | 395,626 | |
| 3/10/2014 | Jorge Valdes | Insider | Sell | 16,000 | $46.57 | $745,120.00 | 203,003 | |
| 3/5/2014 | Jeffrey Moy | SVP | Sell | 10,000 | $47.30 | $473,000.00 | 187,485 | |
| 3/5/2014 | Terrance Gregg | CEO | Sell | 111,890 | $47.46 | $5,310,299.40 | 212,813 | |
| 3/3/2014 | Terrance Gregg | CEO | Sell | 40,000 | $44.87 | $1,794,800.00 | 212,813 | |
| 2/26/2014 | Jess Roper | CFO | Sell | 25,000 | $45.20 | $1,130,000.00 | 66,508 | |
| 2/25/2014 | Steven Robert Pacelli | EVP | Sell | 33,368 | $44.93 | $1,499,224.24 | 195,865 | |
| 1/23/2014 | Steven Robert Pacelli | EVP | Sell | 14,000 | $36.49 | $510,860.00 | 195,865 | |
| 1/21/2014 | Jess Roper | CFO | Sell | 8,000 | $37.38 | $299,040.00 | 65,808 | |
| 12/18/2013 | Jess Roper | CFO | Sell | 8,000 | $34.48 | $275,840.00 | 65,808 | |
| 12/13/2013 | Terrance Gregg | CEO | Sell | 50,000 | $34.41 | $1,720,500.00 | 212,813 | |
| 12/12/2013 | Nicholas Augustinos | Director | Sell | 11,321 | $34.40 | $389,442.40 | 11,130 | |
| 12/10/2013 | Nicholas Augustinos | Director | Sell | 97,541 | $33.64 | $3,281,279.24 | 22,451 | |
| 12/5/2013 | Terrance Gregg | CEO | Sell | 20,000 | $34.77 | $695,400.00 | 212,813 | |
| 12/3/2013 | Andrew Balo | SVP | Sell | 14,268 | $34.21 | $488,108.28 | 124,297 | |
| 11/15/2013 | Terrance Gregg | CEO | Sell | 35,000 | $32.74 | $1,145,900.00 | 212,813 | |
| 9/3/2013 | Terrance Gregg | CEO | Sell | 9,000 | $27.00 | $243,000.00 | 212,813 | |
| 8/1/2013 | Terrance H Gregg | CEO | Sell | 9,000 | $22.15 | $199,350.00 | | |
| 7/1/2013 | Terrance H Gregg | CEO | Sell | 9,000 | $22.87 | $205,830.00 | | |
| 6/13/2013 | Andrew K Balo | SVP | Sell | 10,000 | $21.90 | $219,000.00 | | |
| 6/11/2013 | Jess Roper | CFO | Sell | 10,361 | $22.33 | $231,361.13 | | |
| 6/11/2013 | John Lister | VP | Sell | 2,000 | $22.43 | $44,860.00 | | |
| 6/11/2013 | Steven Robert Pacelli | EVP | Sell | 5,000 | $22.31 | $111,550.00 | | |
| 6/4/2013 | Terrance H Gregg | CEO | Sell | 19,000 | $21.32 | $405,080.00 | | |
| 5/15/2013 | Jeffrey Moy | SVP | Sell | 5,000 | $19.97 | $99,850.00 | | |
| 5/13/2013 | Andrew K Balo | SVP | Sell | 45,000 | $19.40 | $873,000.00 | | |
| 5/9/2013 | Richard Doubleday | SVP | Sell | 1,272 | $19.56 | $24,880.32 | | |
| 3/13/2013 | Andrew K Balo | SVP | Sell | 15,416 | $16.53 | $254,826.48 | | |
| 3/11/2013 | Jay S Skyler | Director | Buy | 70,000 | $15.50 | $1,085,000.00 | | |
| 3/11/2013 | John Lister | VP | Sell | 4,500 | $15.75 | $70,875.00 | | |
| 3/11/2013 | Richard Doubleday | SVP | Sell | 5,100 | $15.63 | $79,713.00 | | |
| 2/1/2013 | Terrance H Gregg | CEO | Sell | 9,000 | $15.08 | $135,720.00 | | |
| 12/3/2012 | Terrance H Gregg | CEO | Sell | 5,000 | $13.24 | $66,200.00 | | |
| 9/4/2012 | Terrance H Gregg | CEO | Sell | 15,000 | $13.46 | $201,900.00 | | |
(Data available from 1/1/2013 forward)
Dexcom (NASDAQ DXCM) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Dexcom (DXCM) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 25 at 5:38 AM |
 | New Review of Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach ...
www.prnewswire.com - April 24 at 9:14 AM |
| Dexcom (DXCM) Set to Announce Earnings on Monday
www.americanbankingnews.com - April 23 at 7:32 AM |
 | Form 4 DEXCOM INC For: Apr 16 Filed by: GREGG TERRANCE H
www.streetinsider.com - April 19 at 9:14 AM |
| Head to Head Contrast: Dexcom (DXCM) & Baxter International (BAX)
www.americanbankingnews.com - April 19 at 8:42 AM |
| Insider Selling: Dexcom (DXCM) Insider Sells 10,000 Shares of Stock
www.americanbankingnews.com - April 18 at 10:10 PM |
| Dexcom (DXCM) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - April 17 at 5:27 PM |
| Dexcom (DXCM) Downgraded by BidaskClub
www.americanbankingnews.com - April 16 at 6:31 PM |
| BidaskClub Downgrades Dexcom (DXCM) to Strong Sell
www.americanbankingnews.com - April 14 at 5:51 PM |
| Dexcom (DXCM) Given a $92.00 Price Target at Oppenheimer
www.americanbankingnews.com - April 14 at 11:49 AM |
| Dexcom's (DXCM) Outperform Rating Reiterated at BMO Capital Markets
www.americanbankingnews.com - April 14 at 9:59 AM |
| TheStreet Upgrades Dexcom (DXCM) to C-
www.americanbankingnews.com - April 13 at 10:53 AM |
| This Morning's Technical Outlook on Medical Research Stocks -- Bruker, Charles River Labs, DexCom, and Exact ...
www.prnewswire.com - April 12 at 10:07 AM |
 | Edited Transcript of DXCM presentation 6-Mar-17 9:00pm GMT
finance.yahoo.com - April 12 at 10:07 AM |
| Dexcom (DXCM) Sees Significant Growth in Short Interest
www.americanbankingnews.com - April 12 at 2:18 AM |
| BidaskClub Upgrades Dexcom (DXCM) to Sell
www.americanbankingnews.com - April 11 at 10:10 PM |
| Analysts Anticipate Dexcom (DXCM) Will Post Quarterly Sales of $172.68 Million
www.americanbankingnews.com - April 11 at 6:05 AM |
| Dexcom's (DXCM) Buy Rating Reaffirmed at Stephens
www.americanbankingnews.com - April 9 at 1:19 PM |
| DexCom (DXCM): Notes From Mass General Expert Call - Piper Jaffray
www.streetinsider.com - April 9 at 9:30 AM |
| UPDATE: DexCom (DXCM) PT Raised to $78 at Stephens; Reiterates Overweight
www.streetinsider.com - April 9 at 9:30 AM |
| -$0.32 Earnings Per Share Expected for Dexcom (DXCM) This Quarter
www.americanbankingnews.com - April 9 at 1:22 AM |
 | DexCom Schedules First Quarter 2018 Earnings Release and Conference Call for May 2, 2018 at 4:30 pm Eastern Time.
www.businesswire.com - April 4 at 4:53 PM |
| DexCom Schedules First Quarter 2018 Earnings Release and Conference Call for May 2, 2018 at 4:30 p.m. Eastern Time.
finance.yahoo.com - April 4 at 4:53 PM |
| Here's Why Senseonics Holdings Inc. Is Rising Today
finance.yahoo.com - April 4 at 4:53 PM |
| Dexcom (DXCM) Now Covered by Analysts at Goldman Sachs
www.americanbankingnews.com - April 4 at 8:04 AM |
| Dexcom (DXCM) Receives New Coverage from Analysts at Guggenheim
www.americanbankingnews.com - April 3 at 9:18 PM |
 | Jefferies Has 4 Health Care and Technology Stock Buys to Start Q2
247wallst.com - April 3 at 9:34 AM |
 | DexCom Is A Takeover Candidate - Cramer's Lightning Round (3/29/18)
seekingalpha.com - April 2 at 9:45 AM |
| Dexcom (DXCM) Given New $57.00 Price Target at Barclays
www.americanbankingnews.com - April 1 at 10:20 PM |
| Dexcom (DXCM) Raised to Hold at ValuEngine
www.americanbankingnews.com - April 1 at 7:35 PM |
| DexCom, Inc. (DXCM) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 31 at 5:42 AM |
| DexCom (DXCM) Lifted to Strong-Buy at BidaskClub
www.americanbankingnews.com - March 30 at 6:14 PM |
| DexCom (DXCM) Given a $80.00 Price Target by Piper Jaffray Analysts
www.americanbankingnews.com - March 29 at 11:25 AM |
| DexCom (DXCM) PT Set at $80.00 by Oppenheimer
www.americanbankingnews.com - March 29 at 11:11 AM |
| DexCom (DXCM) Upgraded to "Outperform" by BMO Capital Markets
www.americanbankingnews.com - March 29 at 8:36 AM |
| DexCom (DXCM) Given "Positive" Rating at Canaccord Genuity
www.americanbankingnews.com - March 29 at 8:36 AM |
| DexCom (DXCM) PT Raised to $80 at Piper Jaffray, Recommends Buying Shares
www.streetinsider.com - March 28 at 4:34 PM |
| DexCom (DXCM) PT Raised to $85 at Cowen on FDA Approval of G6 CGM System; 'Upside to 2018/2019 Revenue ...
www.streetinsider.com - March 28 at 4:34 PM |
| DexCom's (DXCM) Sell Rating Reaffirmed at Northland Securities
www.americanbankingnews.com - March 28 at 12:58 PM |
| FDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes
finance.yahoo.com - March 28 at 9:31 AM |
| Richard Doubleday Sells 2,581 Shares of DexCom, Inc. (DXCM) Stock
www.americanbankingnews.com - March 27 at 10:33 PM |
| FDA approves DexCom's glucose monitoring system
finance.yahoo.com - March 27 at 4:30 PM |
| FDA OKs DexCom G6 integrated CGM system
seekingalpha.com - March 27 at 4:26 PM |
| DexCom (DXCM) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - March 27 at 3:30 PM |
| Today’s Research Reports on Trending Tickers: DexCom and Solid Biosciences
finance.yahoo.com - March 26 at 9:41 AM |
| Analysts Anticipate DexCom, Inc. (DXCM) Will Post Quarterly Sales of $172.80 Million
www.americanbankingnews.com - March 25 at 9:58 AM |
| DexCom (DXCM) Downgraded to Hold at BidaskClub
www.americanbankingnews.com - March 25 at 12:16 AM |
| Baird Upgrades DexCom (DXCM) to Outperform
www.streetinsider.com - March 24 at 4:33 PM |
| DexCom (DXCM) Given Buy Rating at Northcoast Research
www.americanbankingnews.com - March 24 at 12:06 PM |
| Piper Jaffray Companies Analysts Give DexCom (DXCM) a $78.00 Price Target
www.americanbankingnews.com - March 23 at 6:50 PM |
Dexcom (NASDAQ:DXCM) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Dexcom (NASDAQ:DXCM) Income Statement, Balance Sheet and Cash Flow Statement
Dexcom (NASDAQ DXCM) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
